Granimax Tablet DT

产品概览

About Granimax Tablet DT

Granimax Tablet DT is a medication containing the active ingredient Granisetron, classified as Serotonin 5-HT3 antiemetic. Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata.

Key Benefits & Uses

• Used for: INDICATIONS AND USAGE Granisetron is indicated for the prevention of: Nausea and vomiting associated with initial and repeat courses of emetogenic.
• Used for: Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Granisetron, the active ingredient in Granimax Tablet DT, belongs to the Serotonin 5-HT3 antiemetic class. INDICATIONS AND USAGE Granisetron is indicated for the prevention of: Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Granimax Tablet DT. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Granimax Tablet DT for extended periods without medical advice.